TransMedics (TMDX) Capital Expenditures (2018 - 2026)

TransMedics' Capital Expenditures history runs 9 years deep, the most recent figure standing at $36.7 million for Q1 2026.

• In Q1 2026, Capital Expenditures rose 3126.85% year-over-year to $36.7 million; the TTM figure through Mar 2026 stood at $37.3 million (up 1747.08% YoY), while the FY2025 annual figure was $1.8 million, down 14.99% from the prior year.
• Capital Expenditures was $36.7 million for Q1 2026 at TransMedics, up from -$42.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $42.5 million in Q3 2025 to a low of -$42.0 million in Q4 2025.
• Historically, Capital Expenditures has averaged $3.2 million across 5 years, with a median of $730000.0 in 2023.
• The sharpest annual moves came in 2022 and 2025: Capital Expenditures jumped 9665.0% in 2022, then tumbled 3808.83% in 2025.
• A 5-year view of Capital Expenditures shows it stood at $11.0 million in 2022, then slumped by 93.35% to $730000.0 in 2023, then soared by 55.07% to $1.1 million in 2024, then sank by 3808.83% to -$42.0 million in 2025, then surged by 187.31% to $36.7 million in 2026.
• The last three Capital Expenditures figures came in at $36.7 million (Q1 2026), -$42.0 million (Q4 2025), and $42.5 million (Q3 2025), per Business Quant data.